Marilena Vrana: The Final Day of IPPC 2026
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“The final day of IPPC 2026 was incredibly impactful.
The day got off to a fast start with David Osgathorp, a leading expert on professional performance and resilience from Red Bull Racing and Red Bull Technology.
His lessons learned from working with professional athletes set the tone for a dynamic and engaging panel on the next generation of leadership in the unique plasma sector.
I will be reflecting on some of these profound insights as my own career continues in this space.
The panel set the direction for how PPTA Europe can further engage and support the next generation.
Today’s final panels pushed us to think bigger about donor health and safety, as well as what it would really take to boost plasma collection in Europe.
International Plasma Protein Congress is an opportunity for ideas to turn into action, and this year truly delivered.
Already looking ahead to IPPC2027 in Barcelona, now less than a year away.
Let’s keep the momentum going!
See you on 20-21 April 2027.
More posts featuring Marilena Vrana on Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers